Analysing Adverse Event Databases: Principles, Challenges, and Examples.

Publication date: Aug 01, 2025

Databases of reported adverse events after vaccination are used to detect alarming signals by qualitative methods (case series) and quantitative methods (the proportional reporting ratio). This methodological-empirical paper explores several key questions: How useful are these databases for detecting alarming signals? To which study design do they correspond? Which measure of association should be computed? Which key biases might operate, and what can be done to avoid or reduce them? A contemporary methodological tool-causal diagrams-was used to answer these questions. The analytical approach was demonstrated for three possible outcomes of Covid vaccines: Thrombosis with Thrombocytopenia Syndrome, Guillain-BarrcE9 Syndrome, and reported death. A database of reported adverse events corresponds to a case-control study and should be analysed accordingly. The preferred measure of association is the odds ratio, not the proportional reporting ratio. Reporting bias operates to overestimate the true odds ratio, whereas control selection bias operates in the opposite direction (underestimation). As illustrated by three examples of reported death, the magnitude of the biases depends on the choice of the reference vaccine. However, extended methodological and empirical work is needed. Databases of reported adverse events after vaccination are a rich source for quantitative research, provided that several methodological guidelines are followed. These databases should be analysed according to the principles of a case-control study, and the inference should be drawn on a case-by-case basis. It is crucial to estimate the reporting accuracy of a particular event by the type of vaccine, and only a clinical evaluation of a sample of records can provide this information.

Concepts Keywords
Covid Case-Control Studies
Databases COVID-19
Empirical COVID-19 Vaccines
Thrombocytopenia COVID-19 Vaccines
Vaccine Databases, Factual
Guillain-Barre Syndrome
Humans
Thrombocytopenia
Thrombosis

Semantics

Type Source Name
disease MESH Thrombosis
disease MESH Thrombocytopenia
disease MESH Syndrome
disease MESH death
disease MESH Adverse Drug Reaction
disease MESH COVID-19
disease MESH Guillain-Barre Syndrome

Original Article

(Visited 11 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *